ClinicalTrials.Veeva

Menu

Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture

S

Soon Chun Hyang University

Status and phase

Unknown
Phase 4

Conditions

Klatskin's Tumor
Bile Duct Obstruction

Treatments

Device: DLS insertion
Device: SEMS insertion

Study type

Interventional

Funder types

Other

Identifiers

NCT01125865
SCH-2010-04

Details and patient eligibility

About

The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making palliative endoscopic drainage the principal therapeutic option. However, the optimal endoscopic management strategy is contentious. Almost all of the published data comparing plastic and metallic stents relate to distal tumors (those of the pancreas, common bile duct and ampulla). Stent patency, complication rates, and cost-effectiveness have favored metallic stents when compared with plastic stents in patients with distal malignant obstruction expected to live at least 3 to 6 months.

There are few comparative study as to whether self-expanding metallic or plastic stent, especially DLS (double layer plastic stent) are preferable in the technical success, stent patency, and cost-effectiveness for palliating malignant hilar obstruction.

The study was designed to compare the the technical success, stent patency, and cost-effectiveness of self-expandable metal stent and DLS in patients with malignant hilar obstruction.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years old
  • Patient with malignant hilar obstruction

Exclusion criteria

  • No written informed consent
  • Patient with uncorrectable severe coagulopathy
  • Indication for surgical operation
  • Karnofsky score < 60%

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

SEMS
Active Comparator group
Description:
Self-expandable metallic stent will be inserted for the malignant hilar obstruction.
Treatment:
Device: SEMS insertion
DLS
Active Comparator group
Description:
DoubleLayer plastic stent (Olympus) will be inserted for malignant hilar obstruction.
Treatment:
Device: DLS insertion

Trial contacts and locations

4

Loading...

Central trial contact

Tae Hoon Lee, MD; Do Hyun Park, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems